Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GeneTether Therapeutics, Inc. (TSE:GTTX)
CNQX:GTTX
Holding TSE:GTTX?
Track your performance easily
GTTX Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.02 - C$0.11
Previous CloseC$0.04
Volume9.73K
Average Volume (3M)16.84K
Market Cap
C$1.37M
Enterprise Value-C$69.62K
Total Cash (Recent Filing)$1.03M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.91
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding38,744,674
10 Day Avg. Volume10,150
30 Day Avg. Volume16,839
Standard Deviation0.51
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)3.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GeneTether Therapeutics, Inc. News
PremiumCompany Announcements
GeneTether Therapeutics Reveals Q3 Results and New Drug Plans
PremiumCompany Announcements
GeneTether Advances Cancer Treatment and LeadershipPremiumCompany Announcements
GeneTether Shifts Focus After Q2 Financial Report
PremiumCompany Announcements
GeneTether Reports Q1 Financials, Explores New StrategiesGTTX FAQ
What was GeneTether Therapeutics, Inc.’s price range in the past 12 months?
GeneTether Therapeutics, Inc. lowest stock price was C$0.01 and its highest was C$0.11 in the past 12 months.
What is GeneTether Therapeutics, Inc.’s market cap?
Currently, no data Available
When is GeneTether Therapeutics, Inc.’s upcoming earnings report date?
GeneTether Therapeutics, Inc.’s upcoming earnings report date is Apr 24, 2025 which is in 149 days.
How were GeneTether Therapeutics, Inc.’s earnings last quarter?
GeneTether Therapeutics, Inc. released its earnings results on Nov 22, 2024. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is GeneTether Therapeutics, Inc. overvalued?
According to Wall Street analysts GeneTether Therapeutics, Inc.’s price is currently Overvalued.
Does GeneTether Therapeutics, Inc. pay dividends?
GeneTether Therapeutics, Inc. does not currently pay dividends.
What is GeneTether Therapeutics, Inc.’s EPS estimate?
GeneTether Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GeneTether Therapeutics, Inc. have?
GeneTether Therapeutics, Inc. has 34,250,840 shares outstanding.
What happened to GeneTether Therapeutics, Inc.’s price movement after its last earnings report?
GeneTether Therapeutics, Inc. reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of GeneTether Therapeutics, Inc.?
Currently, no hedge funds are holding shares in TSE:GTTX
---
GeneTether Therapeutics, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
166.66%
12-Months-Change
Fundamentals
Return on Equity
-58.24%
Trailing 12-Months
Asset Growth
-30.15%
Trailing 12-Months
Company Description
GeneTether Therapeutics, Inc.
GeneTether Therapeutics Inc is an innovative genetic medicines company. It is engaged in creating best in class gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.
---
Technical Analysis
---